Plan B Articles
Bayer expects EU launch of new long-term contraceptive system Jaydess in 2nd-qtr 2013
6 December 2012
Watson gains exclusive US rights to HRA Pharma’s ulipristal and Abbott makes deal with Fabre for MAb
2 February 2010
US FDA warns four drugmakers on inaccurate promotion
13 January 2010
HRA Pharma's ellaOne cleared across Europe
28 May 2009
Bayer debuts first TV ad for Levonelle in UK
29 April 2009
US Court orders Plan B pill to be OTC for 17 year olds
30 March 2009
Free morning-after pill for UK
22 December 2008
Barr's LoSeasonique approved in the USA
3 November 2008
Bayer signs deal to supply contraceptives to developing nations
1 September 2008
Sosei closer to releasing first ever Japanese ECP
21 July 2008
Bayer's 4th-qtr 2007 profit plummets 76% to 67M euros, well below analyst expectations
10 March 2008
Barr's 3rd-qtr income falls 26% on Pliva costs
26 November 2007
Barr's Portia approved and launched in Canada
3 September 2007
Barr's second-qtr 2007 profit halves to $45.3M
20 August 2007
Wyeth's Lybrel now on sale in USA
6 August 2007
Wyeth's 2nd-qtr net income climbs 12.5%
30 July 2007
Stock Commentary - New York week to July 23, 2007
30 July 2007
Poland
11 June 2007
Wyeth's Lybrel approved by FDA
28 May 2007
FDA faces Plan B law suit for OTC approval
23 April 2007
Headlines 25 years ago this week....
26 February 2007
Bayer Schering's Mirena cleared in Japan
12 February 2007
Public Citizen calls for US FDA to ban third-gen oral contraceptives
12 February 2007
Japan's Sosei initiates Ph I NorLevo study
27 November 2006
New Republican "hold" on FDA Commissioner
27 November 2006
Wyeth unveils seven late-stage drugs for 11 indications at its annual R&D presentation
16 October 2006
New GOP block to FDA Commissioner approval
25 September 2006
US FDA clears Barr's Plan B for OTC use
4 September 2006
Stock Commentary - New York week to Aug 28, 2006
4 September 2006
Plan B approved for over 18 OTC sale by FDA
4 September 2006
Barr resubmits troubled Plan B to US regulator
28 August 2006
Now US anti-abortion groups block FDA appointment
28 August 2006
FDA Plan B initiative criticized from all sides
7 August 2006
Wyeth's revenues hit $5.2B for 1st-half 2006
31 July 2006
$150,000 to Clinton from 'price-gouging' pharma
24 July 2006
Lybrel receives an FDA approvable letter
10 July 2006
FDA's Plan B refusal continues political storm
26 June 2006
FDA warns Wyeth about Puerto Rico plant
5 June 2006
Stock Commentary - New York week to May 22, 2006
29 May 2006
ACOG: Strong data on Wyeth's Lybrel
15 May 2006
Ex-FDA Commissioner in criminal probe
8 May 2006
Wyeth's 1st-qtr 2006 revenues $4.8B, up 6%
1 May 2006
FDA nominee: "no political pressure"
27 March 2006
FDA Commissioner nomination looms
20 March 2006
Schering AG's osteoperosis patch gets US go ahead
9 January 2006
US FDA accepts NDA on Wyeth's birth-control pill
8 August 2005
Barr's Duramed acquires exclusive rights to Nordette
10 January 2005
Spain mulling free "morning-after" pill
22 November 2004
Barr completes sales force integration
25 October 2004
Barr excercises royalty option on Seasonale
20 September 2004
Schering AG raises 2004 forecast on 2nd-qtr
2 August 2004
FDA set to speed US Rx-OTC switches?
12 July 2004
Barr's 3rd-qtr revenues rocket 87%
10 May 2004
Schering AG's 1st-qtr beats expectations
3 May 2004
Barr says FDA extends PDUFA deadline on Plan B
23 February 2004
UPDATE: Schering AG reports 6% "organic" sales growth for 2003, but conservative outlook
16 February 2004
Schering AG's Climara Pro launched in USA
16 February 2004
Barr 2nd-qtr turnover rockets 79%
16 February 2004
Barr to swallow Pan-B for $20 million
13 October 2003
Barr's Seasonale gets approval from FDA
15 September 2003
Gedeon Richter sees product mix improve in 2002
21 April 2003
Schering AG beats forecasts in 2002
10 March 2003
Update: Sales up 11% at Schering AG
10 March 2003
Schering AG's 2002 sales disappoint
10 February 2003
Schering AG US sales up 22% in Q2
5 August 2002
Barr gets OK for generic Nordette in USA
3 June 2002
Barr to file novel OC in mid-2002
13 May 2002
Schering AG CEO optimistic about firm's future prospects
22 April 2002
Barr's generic Levlite OKed in USA
8 April 2002
Net income up 24% at Schering AG as Betaferon sales stay strong
11 February 2002
Irish FPA calls for OTC morning-after pill
14 January 2002
Net income up 23% at Schering AG as Betaferon sales stay strong
9 November 2001
Huge leap in net income at Duramed Pharmaceuticals
24 October 2001
Chile's Supreme Court votes to ban "morning-after" pill
13 September 2001
Low-dose estrogen effective acne treatment
11 September 2001
FDA raises issues on Schering AG's HRT NDA
5 July 2001
Emergency OCs go OTC in Belgium
5 June 2001
Wyeth's Alesse filed for new indication in USA
23 January 2001
Schering's Mirena cleared in USA
7 December 2000
AHP warning about faulty Norplant
14 September 2000
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Is failure to adopt business process management putting the pharma industry at risk?
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
